142 related articles for article (PubMed ID: 24250551)
1. Role of 5-Hydroxytryptamine 1A Receptors in 6-Hydroxydopmaine-induced Catalepsy-like Immobilization in Rats: a Therapeutic Approach for Treating Catalepsy of Parkinson's Disease.
Eyhani-Rad S; Mohajjel Nayebi A; Mahmoudi J; Samini M; Babapour V
Iran J Pharm Res; 2012; 11(4):1175-81. PubMed ID: 24250551
[TBL] [Abstract][Full Text] [Related]
2. Buspirone improves 6-hydroxydopamine-induced catalepsy through stimulation of nigral 5-HT(1A) receptors in rats.
Nayebi AM; Rad SR; Saberian M; Azimzadeh S; Samini M
Pharmacol Rep; 2010; 62(2):258-64. PubMed ID: 20508280
[TBL] [Abstract][Full Text] [Related]
3. The effect of chronic administration of buspirone on 6-hydroxydopamine-induced catalepsy in rats.
Sharifi H; Mohajjel Nayebia A; Farajnia S
Adv Pharm Bull; 2012; 2(1):127-31. PubMed ID: 24312782
[TBL] [Abstract][Full Text] [Related]
4. Buspirone improves the anti-cataleptic effect of levodopa in 6-hydroxydopamine-lesioned rats.
Mahmoudi J; Nayebi AM; Samini M; Reyhani-Rad S; Babapour V
Pharmacol Rep; 2011; 63(4):908-14. PubMed ID: 22001978
[TBL] [Abstract][Full Text] [Related]
5. Dose-Dependent Effect of Flouxetine on 6-OHDA-Induced Catalepsy in Male Rats: A Possible Involvement of 5-HT1A Receptors.
Sharifi H; Mohajjel Nayebia A; Farajnia S
Adv Pharm Bull; 2013; 3(1):203-6. PubMed ID: 24312836
[TBL] [Abstract][Full Text] [Related]
6. Postsynaptic 5-HT1A receptor stimulation increases motor activity in the 6-hydroxydopamine-lesioned rat: implications for treating Parkinson's disease.
Mignon L; Wolf WA
Psychopharmacology (Berl); 2007 May; 192(1):49-59. PubMed ID: 17265149
[TBL] [Abstract][Full Text] [Related]
7. Fluoxetine improves the effect of levodopa on 6-hydroxy dopamine-induced motor impairments in rats.
Mahmoudi J; Mohajjel Nayebi A; Reyhani-Rad S; Samini M
Adv Pharm Bull; 2012; 2(2):149-55. PubMed ID: 24312786
[TBL] [Abstract][Full Text] [Related]
8. 5-HT(1A) receptor activation improves anti-cataleptic effects of levodopa in 6-hydroxydopamine-lesioned rats.
Mahmoudi J; Mohajjel Nayebi A; Samini M; Reyhani-Rad S; Babapour V
Daru; 2011; 19(5):338-43. PubMed ID: 22615679
[TBL] [Abstract][Full Text] [Related]
9. The effect of acute and repeated administration of buspirone, 8-OHDPAT and fluoxetine on haloperidol-induced extrapyramidal symptoms.
Ahmadi SA; Sabahi M; Haddadi R
Neuropsychopharmacol Hung; 2019 Jun; 21(2):59-68. PubMed ID: 31378723
[TBL] [Abstract][Full Text] [Related]
10. 8-OH-DPAT (5-HT1A agonist) Attenuates 6-Hydroxy- dopamine-induced catalepsy and Modulates Inflammatory Cytokines in Rats.
Sharifi H; Mohajjel Nayebi A; Farajnia S
Iran J Basic Med Sci; 2013 Dec; 16(12):1270-5. PubMed ID: 24570834
[TBL] [Abstract][Full Text] [Related]
11. Involvement of 5-hydroxytryptamine1A receptors in Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice.
Egashira N; Matsuda T; Koushi E; Mishima K; Iwasaki K; Shoyama Y; Fujiwara M
Eur J Pharmacol; 2006 Nov; 550(1-3):117-22. PubMed ID: 17022969
[TBL] [Abstract][Full Text] [Related]
12. Behavioural effects of serotonin agonists and antagonists in the rat and marmoset.
Elliott PJ; Walsh DM; Close SP; Higgins GA; Hayes AG
Neuropharmacology; 1990 Oct; 29(10):949-56. PubMed ID: 2123971
[TBL] [Abstract][Full Text] [Related]
13. 5-HT1A receptor activation and anti-cataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy.
Prinssen EP; Colpaert FC; Koek W
Eur J Pharmacol; 2002 Oct; 453(2-3):217-21. PubMed ID: 12398907
[TBL] [Abstract][Full Text] [Related]
14. Short-Term Treatment with Silymarin Improved 6-OHDA-Induced Catalepsy and Motor Imbalance in Hemi-Parkisonian Rats.
Haddadi R; Eyvari Brooshghalan S; Farajniya S; Mohajjel Nayebi A; Sharifi H
Adv Pharm Bull; 2015 Nov; 5(4):463-9. PubMed ID: 26819917
[TBL] [Abstract][Full Text] [Related]
15. Buspirone improves haloperidol-induced Parkinson disease in mice through 5-HT(1A) recaptors.
Mohajjel Nayebi A A; Sheidaei H
Daru; 2010; 18(1):41-5. PubMed ID: 22615592
[TBL] [Abstract][Full Text] [Related]
16. Somatodendritic and postsynaptic serotonin-1A receptors in the attenuation of haloperidol-induced catalepsy.
Haleem DJ; Shireen E; Haleem MA
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1323-9. PubMed ID: 15588759
[TBL] [Abstract][Full Text] [Related]
17. Postsynaptic 5-HT(1A) receptors mediate an increase in locomotor activity in the monoamine-depleted rat.
Mignon L; Wolf WA
Psychopharmacology (Berl); 2002 Aug; 163(1):85-94. PubMed ID: 12185404
[TBL] [Abstract][Full Text] [Related]
18. Gastrodin microinjection suppresses 6-OHDA-induced motor impairments in parkinsonian rats: insights into oxidative balance and microglial activation in SNc.
Haddadi R; Poursina M; Zeraati F; Nadi F
Inflammopharmacology; 2018 Oct; 26(5):1305-1316. PubMed ID: 29616453
[TBL] [Abstract][Full Text] [Related]
19. Effect of metergoline, fenfluramine, and 8-OHDPAT on catalepsy induced by haloperidol or morphine.
Broekkamp CL; Oosterloo SK; Berendsen HH; van Delft AM
Naunyn Schmiedebergs Arch Pharmacol; 1988 Aug; 338(2):191-5. PubMed ID: 2972934
[TBL] [Abstract][Full Text] [Related]
20. Serotonergic modulation of receptor occupancy in rats treated with L-DOPA after unilateral 6-OHDA lesioning.
Nahimi A; Høltzermann M; Landau AM; Simonsen M; Jakobsen S; Alstrup AK; Vang K; Møller A; Wegener G; Gjedde A; Doudet DJ
J Neurochem; 2012 Mar; 120(5):806-17. PubMed ID: 22117574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]